An application for a EUREKA Eurostars grant from FarmPharma AB (publ) (“FarmPharma” or “Company”) in cooperation with its partners in the framework of an international consortium has been approved. Besides FarmPharma which is a coordinator of the consortium, the Karolinska Institute and two organisations from France and Slovenia participate in the project which is devoted for the development of the InterferOX product for sustainable treatment and prevention of viral and bacterial infections in cattle. The budget of the grant for 2 years is about M€1,6.
“The financing of EUREKA Eurostars gives us the excellent opportunity to jointly develop our product InterferOX which is a game changer in the fight against infections in cattle”, – comments Irina Zaitseva, CEO of FarmPharma.
More about FarmPharma:
FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. For more info please contact Irina Zaitseva, the company’s CEO.